Pioneering 3D Human Tissues for Drug Discovery
Mar 27 | 2025
Organovo Provides Business Update
Read More »Mar 25 | 2025
Organovo Announces Close of the Sale of FXR Program to Eli Lilly and Company
Read More »Mar 19 | 2025
Organovo Announces Reverse Stock Split
Read More »